Release Date: 07/02/13 17:39 Summary: Prospectus Price Sensitive: Yes Download Document 13.86MB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans